55 results
8-K
EX-99.2
MYGN
Myriad Genetics, Inc.
5 May 20
Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results
4:18pm
on sales training during downtime Isolation shifts to prevent broad contamination of lab workers Work distancing and face shields Reduced commission
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
22 Jul 20
Departure of Directors or Certain Officers
7:15am
disease. Dr. Skovronsky received his M.D., Ph.D. from University of Pennsylvania where he also completed sub-specialty training in neuropathology
8-K
EX-99.2
MYGN
Myriad Genetics, Inc.
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
across the portfolio Enable frontline and virtual sales with best-in- class training and support ©2020 Myriad Genetics, Inc. All rights reserved
8-K
EX-99.2
d57 ixqy4gfgtzp
23 Feb 21
Company Continues to Execute Strategic Transformation Plan
4:15pm
CORRESP
5xco5 p7rc
23 Jul 08
Correspondence with SEC
12:00am
ARS
uroc 0lr4e9
17 Apr 24
Annual report to shareholders
4:33pm
ARS
0kozie
12 Apr 23
Annual report to shareholders
4:10pm